
Summit Therapeutics SMMT
€ 13.88
-2.41%
Geschäftsbericht 2025
hinzugefügt 23.02.2026
Summit Therapeutics Kurzfristige Verbindlichkeiten 2011-2026 | SMMT
Kurzfristige Verbindlichkeiten Jährlich Summit Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73 M | 41.7 M | 20.4 M | 38.8 M | 25.6 M | 19.9 M | 13.8 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 73 M | 13.8 M | 33.3 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
324 M | $ 20.7 | -1.24 % | $ 2.61 B | ||
|
Aptorum Group Limited
APM
|
4.34 M | $ 0.84 | - | $ 4.58 M | ||
|
Axsome Therapeutics
AXSM
|
379 M | $ 166.38 | - | $ 8.28 B | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
AbCellera Biologics
ABCL
|
64.3 M | $ 3.82 | - | $ 1.14 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | ||
|
Capricor Therapeutics
CAPR
|
31.3 M | $ 26.86 | -3.83 % | $ 719 M | ||
|
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | ||
|
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | ||
|
Codexis
CDXS
|
23.6 M | $ 1.02 | - | $ 74.9 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
256 M | $ 3.34 | 0.3 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
82.2 M | $ 29.2 | -3.41 % | $ 1.69 B | ||
|
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
Завод ДИОД
DIOD
|
105 M | - | - | - | ||
|
Фармсинтез
LIFE
|
1.02 B | - | - | - | ||
|
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
69.5 M | $ 2.21 | -9.05 % | $ 228 M | ||
|
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
5.75 M | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
10.5 M | $ 4.16 | - | $ 295 M | ||
|
Teligent, Inc.
TLGT
|
23.1 M | - | -13.85 % | $ 16.1 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Viela Bio, Inc.
VIE
|
46 M | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
194 M | $ 13.93 | 0.94 % | $ 5.78 B | ||
|
AbbVie
ABBV
|
43.3 B | $ 234.26 | 0.94 % | $ 414 B | ||
|
Blueprint Medicines Corporation
BPMC
|
261 M | - | - | $ 8.14 B | ||
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | ||
|
AIM ImmunoTech
AIM
|
1.36 M | $ 0.77 | -14.64 % | $ 37 M |